Artemether-lumefantrine
CCOA566A2403
Phase 3 small_molecule completed
Quick answer
Artemether-lumefantrine for Plasmodium Falciparum Malaria is a Phase 3 program (small_molecule) at AVENUE THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AVENUE THERAPEUTICS, INC.
- Indication
- Plasmodium Falciparum Malaria
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed